https://scholars.lib.ntu.edu.tw/handle/123456789/623678
標題: | Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma | 作者: | YU-YUN SHAO Chen, Pai-Sheng LIANG-IN LIN Lee, Bin-Shyun Ling, Andrew ANN-LII CHENG CHIUN HSU DA-LIANG OU |
關鍵字: | DOWN-REGULATION; MICRORNA; CELLS; SERUM; BIOMARKER; CONTRIBUTES; PROGRESSION; INHIBITION; EXPRESSION; DIAGNOSIS | 公開日期: | 11-六月-2022 | 出版社: | SPRINGERNATURE | 卷: | 126 | 期: | 12 | 起(迄)頁: | 1806 | 來源出版物: | British journal of cancer | 摘要: | Sorafenib is one of the standard first-line therapies for advanced hepatocellular carcinoma (HCC). Unfortunately, there are currently no appropriate biomarkers to predict the clinical efficacy of sorafenib in HCC patients. MicroRNAs (miRNAs) have been studied for their biological functions and clinical applications in human cancers. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/623678 | ISSN: | 0007-0920 | DOI: | 10.1038/s41416-022-01759-w |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。